FGA
LXRX icon

Fortis Group Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Fortis Group Advisors’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$61.8K Buy
57,800
+20,000
+53% +$21.4K 0.01% 238
2025
Q1 		$17.4K Buy
+37,800
New +$17.4K ﹤0.01% 263